A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
about
Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapiesCost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews.Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on coughBevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer.Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers.Oral Xeloda plus bi-platinu two-way combined chemotherapy in treatment of advanced gastrointestinal malignanciesPopulation screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature.Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.Survival from lung cancer in England and Wales up to 2001Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: initial survival, local control, and cost observations.Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic Review.Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities
P2860
Q28074716-EDE47F03-6CE7-49A4-8AE7-4A74E27BB65FQ33814897-DDE32D3E-C9B5-4CE2-A241-0D926510AA96Q34297098-11E5C75B-6AA2-4A4A-866E-2C0CA055FA4BQ34450520-1AB76B0D-2358-4301-AD00-5EDC2E4BD4B6Q34565988-692FFED6-BBAF-4865-85BC-A939B45FFEDCQ35615863-1708BF06-DB5B-4834-A314-8123AA3AECE7Q36203194-6ACA57F4-5522-4891-AE1D-936BE992B837Q36612331-CF305B3A-203D-4875-903E-F46297735169Q36917779-4A993A99-6774-48CE-AB72-3FD7F7364668Q37206054-A05E36EE-AF2E-4D07-BCE3-9D8FA7A1B37AQ38608095-BA72AADA-0D8F-4315-9315-FF7FFD42F8E4Q39306543-6709B1D6-022A-442C-AC3E-56CAF3E3D8CE
P2860
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A rapid and systematic review ...... in non-small-cell lung cancer.
@ast
A rapid and systematic review ...... in non-small-cell lung cancer.
@en
A rapid and systematic review ...... in non-small-cell lung cancer.
@nl
type
label
A rapid and systematic review ...... in non-small-cell lung cancer.
@ast
A rapid and systematic review ...... in non-small-cell lung cancer.
@en
A rapid and systematic review ...... in non-small-cell lung cancer.
@nl
prefLabel
A rapid and systematic review ...... in non-small-cell lung cancer.
@ast
A rapid and systematic review ...... in non-small-cell lung cancer.
@en
A rapid and systematic review ...... in non-small-cell lung cancer.
@nl
P2093
P1476
A rapid and systematic review ...... in non-small-cell lung cancer.
@en
P2093
P577
2001-01-01T00:00:00Z